polymorphism of paraoxonase and the risk of coronary heart Arterioscler. Thromb. Vasc. Biol.

,

–

Sanghera, D.K., Aston, C.E., Saha, N., Kamboh, M.I.,

a. polymorphisms in two paraoxonase genes (PON

and PON

) associated with the risk of coronary heart disease. Am. J. Hum.

,

–

Sanghera, D.K., Saha, N., Kamboh, M.I.,

b. The codon polymorphism in the paraoxonase

gene is not associated with risk of coronary heart disease in Asian Indians and Atherosclerosis

,

–

Schachter, F., Faure-Delanef, L., Guenot, F., Rouger, H., Froguel, Lesueur-Ginot, L., Cohen, D.,

Genetic associations with longevity at the APOE and ACE loci. Nat. Genet.

,

–

Senti, M., Tomas, M., Vila, J., Marrugat, J., Elosua, R., Sala, J., Masia,

Relationship of age-related myocardial infarction risk and Arg

variants of the human paraxonase gene in the Regicor Atherosclerosis

,

–

Serrato, M., Marian, A.J.,

A variant of human arylesterase (HUMPONA) gene is a risk factor for coronary disease. J. Clin.Invest.

,

–

Taioli, E., Bonassi, S.,

Pooled analyis of epidemiological involving biological markers. Int. J. Hyg. Environ. Health

–

Terwilliger, J.D., Ott, J.,

Handbook of Human Genetic Linkage. Hopkins University Press, New York. Watson, A.D., Berliner, J.A., Hama, S.Y., La Du, B.N., Faull, Fogelman, A.M., Navab, M.,

Protective effect of lipoprotein associated PON: inhibition of the biological activity minimally oxidised low density lipoprotein. J. Clin. Invest.

–

Yamada, H., Dahl, M.L., Lannfelt, L., Viitanen, M., Winblad, B., F.,

CYP

D

and CYP

C

genotypes in an elderly population. Eur. J. Clin. Pharmacol.

,

–

Zhao, J.H., Sham, P.C.,

Faster allelic association analysis

Heijmans, B.T., Westendorp, R.G.J., Lagaay, A.M., Knook, D.L., Kluft, C., Slagboom, P.E.,

Common paraxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis

,

–

Herrmann, S-M., Blanc, H., Poirier, O., Arveiler, D., Luc, G., Evans, A., Marques-Vidal, P., Bard, J.M., Cambien, F.,

The Gln/Arg polymorphism of human paraoxonase (PON

) is not related to myocardial infarction in the ECTIM study. Atherosclerosis

,

–

Humbert, R., Adler, D.A., Disteche, C.M., Hassett, C., Omiecinski, C.J., Furlong, C.E.,

The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet.

,

–

James, R.W., Leviev, I., Righetti, A.,

Smoking is associated with reduced serum paraoxonase activity and concentration in coronary heart disease. Circulation

,

–

Jarvik, G.P., Rozek, L.S., Brophy, V.H., Hatsukami, T.S., Richter, R.J., Schellenberg, G.D., Furlong, C.E.,

Paraxonase (PON

) pheno- type is a better predictor of vascular disease than is the PON

or PON

genotype. Arterioscl. Thromb. Vasc. Biol.

,

–

Jarvik, G.P., Tsai, N.T., M

instry, L.A., Wani, R., Brophy, V.H., Richter, R.J., Schellenberg, G.D., Heagerty, P.J., Hatsukami, T.S., Furlong, C.E.,

Vitamin C and E intake is associated with increased paraxonase activity. Arterioscler. Thromb. Vasc. Biol.

,

–

Jian-Gang, Z., Yong-Xing, M., Chuan-Fu, W., Pei-Fang, L., Song-Bai, Z., Nui-Fan, G., Guo-Yin, F., Lin, H.,

Apolipoprotein E and longevity among Han Chinese population. Mech. Ageing Dev.

,

–

Kao, Y.L., Donaghue, K., Chan, A., Knight, J., Silink, A.,

A variety of paraoxonase PON

gene is associatedwith diabetic retinopathy in IDDM. J. Clin. Endocrinol. Metab.

,

–

Katzman, R.,

Apolipoprotein E and Alzheimer’s disease. Curr. Opin. Neurobiol.

,

–

Kervinen, K., Savolainen, M.J., Salokannel, J., Hynninen, A., Heikkinen, J., Ehnholm, C., Koistinen, M.J., Kesaniemi, Y.A.,

Apolipoprotein E and B polymorphisms-longevity factors assessed in nonagenarians. Atherosclerosis

,

–

Kuremoto, K., Watanabe, Y., Ohmura, H., Shimada, K., Mokuno, H.I., Daida, H.,

R/R genotype of human paraoxonase (PON

) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. J. Atheroscler. Thromb.

,

–

Leviev, H., Poirier, O., Nicaud, V., Evans, A., Kee, F., Arveile, D., Morrisson, C., Cambien, F., James, R.W.,

High expressor paraxonase PON

gene promoter polymorphism are associated with reduced risk of vascular disease in younger coronary patients. Atherosclerosis

,

–

Mackness, M.I., Arrol, S., Abbott, C.A., Durrington, P.N.,

Protection oflow-densitylipoproteinagainstoxidativemodificationbyhigh-density lipoprotein associated paraoxonase. Atherosclerosis

,

–

Mackness, M.I., Arrol, S., Mackness, B., Durrington, P.N.,

a. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid

paraxonase activity. Arterioscler. Thromb. Vasc. Biol.

, Jian-Gang, Z., Yong-Xing, M., Chuan-Fu, W., Pei-Fang, L., Song-Bai, Nui-Fan, G., Guo-Yin, F., Lin, H.,

Apolipoprotein E longevity among Han Chinese population. Mech. Ageing Dev.

–

Kao, Y.L., Donaghue, K., Chan, A., Knight, J., Silink, A.,

A of paraoxonase PON

gene is associatedwith diabetic retinopathy IDDM. J. Clin. Endocrinol. Metab.

,

–

Katzman, R.,

Apolipoprotein E and Alzheimer’s disease. Curr. Neurobiol.

,

–

Kervinen, K., Savolainen, M.J., Salokannel, J., Hynninen, A., Heikkinen, Ehnholm, C., Koistinen, M.J., Kesaniemi, Y.A.,

E and B polymorphisms-longevity factors assessed in Atherosclerosis

,

–

Kuremoto, K., Watanabe, Y., Ohmura, H., Shimada, K., Mokuno, Daida, H.,

R/R genotype of human paraoxonase (PON

) is protective against lipoprotein oxidation and coronary artery disease Japanese subjects. J. Atheroscler. Thromb.

,

–

Leviev, H., Poirier, O., Nicaud, V., Evans, A., Kee, F., Arveile, Morrisson, C., Cambien, F., James, R.W.,

High paraxonase PON

gene promoter polymorphism are associated reduced risk of vascular disease in younger coronary Atherosclerosis

,

–

Mackness, M.I., Arrol, S., Abbott, C.A., Durrington, P.N.,

lipoprotein associated paraoxonase. Atherosclerosis

,

–